MedTrace Logo

Study of Yili "Changqing" Pro-ABB Yoghurt in the Improvement of Human Gastrointestinal Tract System

NCT01682798 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2012-10-25

No results posted yet for this study

Summary

The purpose of this study is to determine whether Yili "Chang Qing" Pro-ABB yoghurt is effective in improving mild constipation and the intestinal micro-ecology environment \& alimentation.

Conditions

Interventions

DIETARY_SUPPLEMENT

Placebo yoghurt

100g of placebo yoghurt will be taken at 10:00 am and 4:00 pm, respectively; 2 times per day.

DIETARY_SUPPLEMENT

Yili "Chang Qing" Pro-ABB yoghurt (Formula 1)

100g of Yili "Chang Qing" Pro-ABB yoghurt will be taken by at 10:00 am and 4:00 pm, respectively; 2 times per day.

DIETARY_SUPPLEMENT

Yili "Chang Qing" Pro-ABB yoghurt (Formula 2)

Sponsors & Collaborators

  • Inner Mongolia Yili Industrial Group Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Ying An, Ph.D · Inner Mongolia Hilo Industrial Group Co., Ltd

  • Donglian Cai · Changhai Hospital of Shanghai, Nutriology Dept.

  • Xinwang Gao · Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Geriatric Medicine Dept..

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2009-06-30
Completion
2009-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01682798 on ClinicalTrials.gov